Literature DB >> 33525242

COVID-19 and NF-kB: The Hepcidin paradox and the Iron Storm - Reply.

Filippo Banchini1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33525242      PMCID: PMC7927502          DOI: 10.23750/abm.v91i4.10904

Source DB:  PubMed          Journal:  Acta Biomed        ISSN: 0392-4203


× No keyword cloud information.
To the Editor, The additional arguments supported by Sukhomlin (1) in the letter above could represent an essential aid in comprehending COVID infection and constitute important support in developing and deepening iron metabolism interaction in this affection. The first impression we can get reading the commentary seems to contrast with our observations about hepcidin. The ancestral role of hepcidin has the function to preserve from bacterial infection, reducing the availability of free iron outside the cell; thus, the bacteria minimize replication capability. The same effect is present in macrophages that incorporate iron and expel it as ferritin (2). Also, in pneumocytes, the effect exerted by direct production of Interleukine-6 and hepcidin is to reduce intralveolar iron; in fact, ferroportin is expressed on the alveolar surface (3,4) (see Figure 1 for better explanation).
Figure 1.

A) Pneumocytes distribution of Ace2 Receptor, ferroportin and transferrin receptors; B) Intracellular iron movements; C) Ace2 receptor stimulation and activation of NF-κB pathway with implementation of hepcidin, IL-6 and transferrin receptors; D) Ferroportin internalization trough hepcidin action and transferrin receptor exposition; E) Transferrin internalization with labile iron pool accumulation and initial Fenton chemistry; F) Excess of intracellular iron and consequent ferroptosis with free iron delivery and Macrophage iron capitation.

A) Pneumocytes distribution of Ace2 Receptor, ferroportin and transferrin receptors; B) Intracellular iron movements; C) Ace2 receptor stimulation and activation of NF-κB pathway with implementation of hepcidin, IL-6 and transferrin receptors; D) Ferroportin internalization trough hepcidin action and transferrin receptor exposition; E) Transferrin internalization with labile iron pool accumulation and initial Fenton chemistry; F) Excess of intracellular iron and consequent ferroptosis with free iron delivery and Macrophage iron capitation. In the commentary proposed by Hirano (5), the Sars-Cov-2 virus links the ACE2 receptor of the alveolar cell by activating the NF-κB factor for its replication. The NF-κB requires iron for its activation by the complex IKK - IκB - NF-κB (6). The consequence of NF-kb activation stimulates hepcidin and IL-6 production (7). IL-6 also stimulates hepcidin and transferrin receptor 1 with consequent transferrin internalization (8) and iron accumulation in the alveolar cell. The intracellular iron persists the NF-κB activation (6). When this sequence is too accelerated, it causes an overcharge of intracellular iron and consequent ferroptosis (9). Ferroptosis itself and IL-6 production maintain hepcidin expression in macrophages, with the aim of iron sequestration, converting it to ferritin (2). Disruption of alveolar epithelium by ferroptosis releases several pro-inflammatory, procoagulant molecules and free iron ions in the blood torrent (10). The consequence of all these processes is the contemporary use of hepcidin as a viral helper in replication and a defense immunity activator, consisting of a “Hepcidin paradox and an iron storm”. Understanding if cytokine storm could be restricted to an iron storm could be a target to address our treatments. Several authors (11,12) previously observed the same conclusion, underlining the NF-κB pathway’s simultaneous use for viral replication and immunity reaction. A better comprehension of these two distinct phases could be useful in understanding COVID infection.

Conclusion

In her letter, the demonstrations reported by Sukhomlin added to our clinical observations suggest considering iron metabolism and the adverse effects promoted by non-transferrin bound iron, a topic to be deepened in the understanding and treating COVID infection.
  12 in total

1.  Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells.

Authors:  Douglas B Kell; Etheresia Pretorius
Journal:  Metallomics       Date:  2014-04       Impact factor: 4.526

Review 2.  Recent advances on viral manipulation of NF-κB signaling pathway.

Authors:  Jun Zhao; Shanping He; Arlet Minassian; Junhua Li; Pinghui Feng
Journal:  Curr Opin Virol       Date:  2015-09-15       Impact factor: 7.090

3.  Interleukin-6 enhances hepatic transferrin uptake and ferritin expression in rats.

Authors:  M Kobune; Y Kohgo; J Kato; E Miyazaki; Y Niitsu
Journal:  Hepatology       Date:  1994-06       Impact factor: 17.425

Review 4.  NF-kappaB and virus infection: who controls whom.

Authors:  M Gabriella Santoro; Antonio Rossi; Carla Amici
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

5.  [Experimental study on transcription regulation of mouse hepcidin gene by NF-kB].

Authors:  Rong-xia Liao; Jian-guo Sun; Xiao-lin Zhong; Jian-xin Zhou; Yuan-zhong Wang
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2006-02

6.  Signaling role of intracellular iron in NF-kappaB activation.

Authors:  Shigang Xiong; Hongyun She; Heigo Takeuchi; Bora Han; John F Engelhardt; C H Barton; Ebrahim Zandi; Cecilia Giulivi; Hidekazu Tsukamoto
Journal:  J Biol Chem       Date:  2003-03-11       Impact factor: 5.157

7.  The Role of Iron Metabolism in Lung Inflammation and Injury.

Authors:  Jonghan Kim; Marianne Wessling-Resnick
Journal:  J Allergy Ther       Date:  2012-01-25

Review 8.  Molecular Mechanisms of Ferroptosis and Its Role in Pulmonary Disease.

Authors:  Ningning Tao; Kang Li; Jingjing Liu
Journal:  Oxid Med Cell Longev       Date:  2020-06-26       Impact factor: 6.543

Review 9.  Iron in Lung Pathology.

Authors:  Vida Zhang; Elizabeta Nemeth; Airie Kim
Journal:  Pharmaceuticals (Basel)       Date:  2019-02-15

10.  COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome.

Authors:  Toshio Hirano; Masaaki Murakami
Journal:  Immunity       Date:  2020-04-22       Impact factor: 31.745

View more
  3 in total

1.  Serum ferritin levels in inflammation: a retrospective comparative analysis between COVID-19 and emergency surgical non-COVID-19 patients.

Authors:  Filippo Banchini; Gaetano Maria Cattaneo; Patrizio Capelli
Journal:  World J Emerg Surg       Date:  2021-03-08       Impact factor: 5.469

Review 2.  COVID-19, Cation Dysmetabolism, Sialic Acid, CD147, ACE2, Viroporins, Hepcidin and Ferroptosis: A Possible Unifying Hypothesis.

Authors:  Attilio Cavezzi; Roberto Menicagli; Emidio Troiani; Salvatore Corrao
Journal:  F1000Res       Date:  2022-01-27

Review 3.  Mucormycosis in the COVID-19 Environment: A Multifaceted Complication.

Authors:  Rohit Sharma; Praveen Kumar; Abdur Rauf; Ashun Chaudhary; Pradeep Kumar Prajapati; Talha Bin Emran; Clara Mariana Gonçalves Lima; Carlos Adam Conte-Junior
Journal:  Front Cell Infect Microbiol       Date:  2022-07-18       Impact factor: 6.073

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.